HNN3.0
Register
Register
Register

Antleron

Company (SME)

www.antleron.com/Leuven, Belgium
3 profile visits

About

Antleron is an R&D company specialized in bespoke cell and gene therapy product and bioprocess modelling, wet lab research & development, and clinical & industrial translation. Antleron’s hybrid bioprocess development platform enables faster, more affordable, and more equitable delivery of cell and gene therapies to patients by integrating scalable, closed and automated bioreactors with AI-driven digital-twins.

From discovery to process development and CMC, Antleron’s smart scale-down model service combines custom, lab-scale, modular bioreactors with its Nexus-driven digital twin platform to predict, develop and optimize clinical-scale bioprocesses and manufacturing systems. Antleron’s CellGuide® fixed-bed upstream bioreactor platform completes its smart scale-down model offering by enabling improved quality, consistency and scalability from lab to patient for bespoke therapies.

Antleron provides R&D in medicinal & diagnostic product and bioprocess modelling, wet lab R&D, and clinical & industrial translation.

Representatives

Co-development Architect

Antleron

Marketplace (1)

  • Project cooperation

    R&D services in bioprocess development and bioreactors for in vitro screening platforms

    Antleron provides R&D in medicinal product and bioprocess modelling, wet lab R&D, and clinical & industrial translation.

    • Partner seeks Consortium/Coordinator
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-05: Pilot actions for follow-on funding: Leveraging EU-funded collaborative research in regenerative medicine
    Author

    Co-development Architect at Antleron

    Leuven, Belgium